Home  »  Ipo Review  »  Sunrest Lifescience Ipo

Let’s have a detailed review of the company and analytics of the Sunrest Lifescience IPO release date, IPO offer price, subscription, Sunrest Lifescience Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.

Face Value Rs 10
Price Band Rs 84
Listing At NSE, SME
Min. Order Quantity 1600 Shares
Listing Date November 20, 2023
Offer for Sale Rs Lakh
Fresh Issue Rs 1085 Lakh
IPO Size Rs 1085 Lakh
Tick Size 1

Sunrest Lifescience IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.

Live Performance – Sunrest Lifescience Share Price

Sunrest Lifescience IPO – Summary

Sunrest Lifescience IPOTheir Company was originally incorporated as “Sunrest Lifescience Private Limited” under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated October 30, 2017, issued by the Registrar of Companies, Ahmedabad.

Subsequently, their Company was converted into a Public Limited Company pursuant to a shareholders resolution passed at the Extra-ordinary General Meeting held on March 09, 2023, and the name of their Company was changed to “Sunrest Lifescience Limited”.

The Promoter of this company is Mr Nikhilkumar Y Thakkar, Mr. Amitbhai Shambhulal Thakkar, Mr. Bhagyesh Kiritbhai Parekh and Mr. Bharatkumar V Thakka. The lead manager of the issue is Mark Corporate Advisors Private Limited, and the Registrar of this issue is Skyline Financial Services Private Limited.

Sunrest Lifescience IPO Date

The opening and closing dates of Sunrest Lifescience IPO are November 7, 2023 and November 9, 2023 respectively.

Sunrest Lifescience IPO Subscription

Day / Date NII RII Total Subscription
1st Day – 7th Nov 0.62x 5.86x 3.24x
2nd Day – 8th Nov 2.67x 19.88x 11.28x
3rd Day – 9th Nov 29.17x 65.74x 48.54x
Shares Offered or Net Issue 612,800 612,800 1,291,200

The shares subscribed by the public will be updated here.

Sunrest Lifescience IPO Allotment Status

Here, you can find the Allotment Status of this IPO.

Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.

Sunrest Lifescience Limited IPO Listing Date

Find the dates below on basis of allotment, refund, listing, and more:

Basis of Allotment Finalization November 15, 2023
Refunds Initiation November 16, 2023
Credit of Shares to Demat Account November 17, 2023
Share Listing Date November 20, 2023

Sunrest Lifescience IPO Price Band

The face value of each share is Rs.10, but the price band of the IPO is Rs.84

Sunrest Lifescience IPO Equity Size

This Initial Public Issue of 1,291,200 Equity Shares of Rs.10 each for cash at a price of Rs.84 per equity share aggregating to Rs.1085 Lakh.

Sunrest Lifescience IPO Share Offering

Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of 1,291,200 Equity Shares of Rs.10/ each.

Issue Size: 1,291,200 Equity Shares of Rs.10 each, aggregating to Rs.1085 Lakh

Open Free Demat Account Now!

    Fill Your Details Here
    1. Open Demat AccountInvest in IPO

    Sunrest Lifescience IPO – Live Performance

    The listing date of this IPO is November 20, 2023. You can check the live performance of the IPO here, only after it is listed on exchanges.

    Live IPO Performance – Sunrest Lifescience Share Price

    Sunrest Lifescience IPO Grey Market Premium

    The Sunrest Lifescience Limited IPO Grey Market Premium price is Rs X, the Kostak rate is Rs X and the Subject to Sauda is Rs X. 

    Sunrest Lifescience IPO – Company Overview

    They deal in Capsules, Tablets, Syrup, Ointment, Gel, Mouth Wash, Solution, Suspension, Dry Powders and Toothpaste. Their product portfolio comprises of wide range of drugs like Anti-Bacterial, Anti Diarrheal, AntiFungal, Anti Malerial, Anti Diabetic, Dental Cure, Anti Protozol, Anti Histamine, Anti-Hypertensive drugs, Cosmetic, Anti Parasitic, Multivitamin, Multimineral, Nutraceutical and Anti-inflammatory.

    Their company have 18 Registered Trademarks for 32 products. The products of the Company are sold to Stockists and Super Stockists & in turn it is available at Chemist shops, Dispensaries, Hospitals etc.

    Their business operations are supported by one of their Group Companies and various third-party manufacturers. They typically work on a third-party manufacturing basis or at times purchase order basis with manufacturers of pharma products, depending upon the customer’s requirement.

    Sunrest Lifescience IPO – Financial Statements

    A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:

    Financial Summary:

    Amount (in INR & Lakh)
    30-Jun-23 31-Mar-23 Mar-22 31-Mar-21
    Total Assets 1706.28 1671.37 1301.97 948.15
    *Total Revenue 563.58 2467.05 2690.99 1694.91
    Total Expense 466.17 2192.66 2585.96 1672.55
    Profit After Tax 75.08 204.31 77.71 16.55

    Earnings per Equity Share (in Lakh)

    30-Jun-23 31-Mar-23 Mar-22 31-Mar-21
    Basic & Diluted 2.50 6.81 2.59 0.55

    Further, their PAT for the period ended on March 31, 2023, March 31, 2022, and March 31, 2021, were Rs. 204.31 Lakh, Rs. 77.71 Lakh and Rs. 16.55 Lakh respectively.

    Sunrest Lifescience IPO – Promoters

    The Promoter of this company is:

    1. Mr. Nikhilkumar Y Thakkar,
    2. Mr. Amitbhai Shambhulal Thakkar,
    3. Mr. Bhagyesh Kiritbhai Parekh
    4. Mr. Bharatkumar V Thakkar

    List of Related Parties (Key Managerial Personnel)

    • Juhi Sawajani, Chairperson and Independent Director
    • Nikhil Kumar Y Thakkar, Managing Director
    • Amitbhai Shambhulal Thakkar, Whole Time Director
    • Bharatkumar V Thakkar, Director

    Sunrest Lifescience IPO – Promoters Holding

    • Pre-Issue Share Holding – 100%
    • Post-Issue Share Holding – 69.91%

    Sunrest Lifescience IPO Offer Details or Issue Details

     Particulars  No. Of Equity Shares
     Equity Shares Offered  Up to 12,91,200 Equity Shares aggregating up to Rs.1084.608 Lakh
    of which:
    Issue Reserved for the Market Makers Up to 65,600 Equity Shares aggregating up to Rs 55.104
    Net Issue to the Public Up to 12,25,600 Equity Shares aggregating up to Rs.1029.504
    Of which:
    Retail Investors Portion Not less than 6,12,800 Equity Shares
    Other than Retail Individual Investors Not more than 6,12,800 Equity Shares
     Equity Shares outstanding prior to the Issue 30,00,000 Equity Shares
     Equity Shares outstanding after the Issue 42,91,200 Equity Shares

    Sunrest Lifescience IPO Issue Object

    Their Company proposes to utilize the Net Proceeds towards funding the following objects:

    1. Meeting Working Capital Requirements
    2. General Corporate Purpose
    3. Meeting Public Issue Expenses

    Sunrest Lifescience IPO – Business Strategy

    • Increasing their local presence
    • Strengthen their marketing network

    Sunrest Lifescience IPO – Basis of Offer Price

    The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

    Qualitative factors are:

    • Experienced Promoters and Management Team
    • Wide range of Products
    • Efficient marketing team

    The relevant quantitative factors are:

    Basic & Diluted EPS RONW (%) NAV (Rs.)
    31-Mar-23 6.81 65.59 10.38
    31-Mar-22 2.59 72.49
    Mar-21 0.55 56.12

    Sunrest Lifescience IPO: Competitive Peers

    Face Value (Rs.) P/E EPS (Rs.) Return on Net Worth (%) Total Income (Rs. in Lakhs)
    Sunrest Lifescience Limited 10 12.33 6.81 5.28 2467.05
    Listed Peers
    Trident Lifeline Limited 10 34.91 5.23 13.18 3,169.22
    Vaishali Pharma Limited 10 21.54 6.26 16.29 7,582.08
    Chandra Bhagat Pharma Limite 10 69.55 1.54 4.23 9,407.56

    Sunrest Lifescience IPO Lead Managers

    Lead Managers
    Mark Corporate Advisors Private Limited
    CIN – U67190MH2008PTC181996
    404/1, The Summit Business Bay, Sant Janabai Road (Service Lane),
    Off W. E. Highway, Vile Parle (East), Mumbai-400 057. Maharashtra, India
    Tel. No.: +91 22 2612 3208
    Email ID: smeipo@markcorporateadvisors.com
    Investor Grievance Email ID: investorgrievance@markcorporateadvisors.com
    Contact Person: Mr. Niraj Kothari
    Website: www.markcorporateadvisors.com; SEBI Regn. No.: INM000012128

    Sunrest Lifescience IPO Registrar to offer

    Registrar to the Offer
    Skyline Financial Services Private Limited
    CIN – U74899DL1995PTC071324
    D-153/ A, First Floor, Okhla Industrial Area,
    Phase – I, New Delhi – 110020
    Telephone – +91 1126812682
    E-mail id: Virenr@Skylinerta.Com
    Investor Grievance Email: grievances@skylinerta.com
    Contact person: Mr. Subhash Dhingreja
    Website: http://www.skylinerta.com/; SEBI Regn. No.: INR000003241

    Sunrest Lifescience IPO – Other Details

    • Statutory Auditor – M/s Madhusudan C Mashruwala & Co
    • Legal Counsel to the Company – Whitespan Law Offices LLP
    • Bankers to the Company – Axis Bank Limited

    Sunrest Lifescience IPO Review by Stock Brokers

    Top Stock Brokers Review Company Reputation Competitive Edge Financial Statement Popularity Index Promoters Reputation
    Angel Broking 7.5/10 7.4/10 8.5/10 8.1/10 7.1/10
    Sharekhan 7.2/10 7.1/10 8.6/10 8.1/10 7.2/10
    Kotak Securities 7.3/10 7.5/10 8.4/10 8.1/10 7.3/10
    ICICI Direct 7.3/10 7.3/10 8.7/10 8.1/10 7.1/10
    IIFL 7.5/10 7.2/10 8.8/10 8.0/10 7.1/10
    Edelweiss 7.5/10 7.4/10 8.4/10 8.3/10 7.2/10
    Zerodha 7.4/10 7.1/10 8.5/10 8.1/10 7.0/10
    5Paisa 7.1/10 7.1/10 8.4/10 8.1/10 7.1/10
    Karvy 7.4/10 7.3/10 8.2/10 8.1/10 7.1/10
    Motilal Oswal 7.1/10 7.1/10 8.6/10 8.3/10 7.2/10


    Subscribe to Sunrest Lifescience IPO

      Fill Your Details Here
      1. Open Demat AccountInvest in IPO

      Sunrest Lifescience Limited IPO News

      News 1 – IPO DRHP Download

      News 2 – IPO RHP Prospectus Download

      Sunrest Lifescience IPO Review FAQs

      Check out various FAQs related to Sunrest Lifescience IPO:

      What is the Issue Size of Sunrest Lifescience IPO?

      The Company is making an initial public offer of 1,291,200 equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.

      What is the Price band of Sunrest Lifescience IPO?

      The price band for this particular IPO ranges between Rs 84. As far as the face value of the share is concerned, it is Rs. 10 per share.

      What is the Sunrest Lifescience IPO Open Date?

      The opening and closing dates for this IPO have been updated. The IPO is set to open on November 7, 2023, while the closing date is set at November 9, 2023.

      What is the Sunrest Lifescience IPO Allotment Date?

      They also have the news regarding the respective allotment dates of this IPO. The basis of Allotment finalization is on November 15, 2023, refund initiation is on November 16, 2023, credit of shares is on November 17, 2023, and share listing date is on November 20, 2023.

      What is the Sunrest Lifescience IPO Listing Date?

      Shares of this company shall be listed in the exchanges on November 20, 2023. The date, when the listing would be done, is stagnant on November 20, 2023.

      Who is the Registrar of Sunrest Lifescience IPO?

      One of the reputed registrars is managing the issue of this IPO, i.e. NA. Their website will help you regarding the further information you are on the lookout for.

      Who is the Promoter of Sunrest Lifescience IPO?

      Here are the promoters of this IPO – Mr Nikhilkumar Y Thakkar, Mr Amitbhai Shambhulal Thakkar, Mr Bhagyesh Kiritbhai Parekh and Mr Bharatkumar V Thakka. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.

      What is the GMP of Sunrest Lifescience IPO?

      They have obtained the GMP of this IPO and it is Rs NA. Further insights into the Kostak rate and subject to sauda or SS are as well included in this report.

      Is Sunrest Lifescience IPO Good for Investment?

      They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.

      What is the PAT of Sunrest Lifescience Company?

      They have the information on company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2023 in Lakh is 204.31, 2022 is 77.71, and 2021 is 16.55. PAT from Jun 2023 is 75.08.

      Calculate your return on investment!

      Asset Class ROI (Rs.) Profit (Rs.) Profit (%)
      Real Estate
      Fixed Deposit
      Mutual Fund

      Featured Topics


      Get 100% IPO Allotment Guarantee! Subscribe to IPO